QUADRANT PHARMACIES LTDActive

Company number 04748706Private limited companyIncorporated 2003

Key figures

£4,325-88.7%
Net assets 2024/25
-54.1%
Average annual change 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, QUADRANT PHARMACIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand107,593169,401119,068101,215101,778
Total assets448,857423,789376,091332,723338,415
Total liabilities250,832273,866290,141291,736329,947
Net assets / total equity192,195145,17882,39138,3184,325
Average number of employees1212131314

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: QUADRANT PHARMACIES LTD

Company

QUADRANT PHARMACIES LTD is a private limited company registered with Companies House under company number 04748706. It was incorporated on 30 Apr 2003. Its status is active. The registered office is in Welwyn (AL6). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were £4,325, down 88.7% on the previous year. Cash at bank and in hand was £101,778. Total assets were £338,415 and total liabilities £329,947. The company had an average of 14 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

3 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 14 May 2027.